BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vičić M, Kaštelan M, Brajac I, Sotošek V, Massari LP. Current Concepts of Psoriasis Immunopathogenesis. Int J Mol Sci 2021;22:11574. [PMID: 34769005 DOI: 10.3390/ijms222111574] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Holmannova D, Borsky P, Andrys C, Krejsek J, Cermakova E, Fiala Z, Hamakova K, Svadlakova T, Parova H, Rehacek V, Poctova G, Borska L. The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants. JPM 2022;12:1965. [DOI: 10.3390/jpm12121965] [Reference Citation Analysis]
2 Costa S, Bevilacqua D, Caveggion E, Gasperini S, Zenaro E, Pettinella F, Donini M, Dusi S, Constantin G, Lonardi S, Vermi W, De Sanctis F, Ugel S, Cestari T, Abram CL, Lowell CA, Rodegher P, Tagliaro F, Girolomoni G, Cassatella MA, Scapini P. Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1049079] [Reference Citation Analysis]
3 Li L, Lu H, Zhang Y, Li Q, Shi S, Liu Y. Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway. CCID 2022;Volume 15:2523-2534. [DOI: 10.2147/ccid.s389760] [Reference Citation Analysis]
4 Zhou Q, Yang L, Li T, Wang K, Huang X, Shi J, Wang Y. Mechanisms and inhibitors of ferroptosis in psoriasis. Front Mol Biosci 2022;9:1019447. [DOI: 10.3389/fmolb.2022.1019447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Brożyna AA, Slominski RM, Nedoszytko B, Zmijewski MA, Slominski AT. Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy. IJMS 2022;23:8575. [DOI: 10.3390/ijms23158575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Holmannova D, Borsky P, Andrys C, Hamakova K, Cermakova E, Poctova G, Fiala Z, Smejkalova J, Blaha V, Borska L. Chromosomal Aberrations and Oxidative Stress in Psoriatic Patients with and without Metabolic Syndrome. Metabolites 2022;12:688. [PMID: 35893255 DOI: 10.3390/metabo12080688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kamata M, Tada Y. Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis. Front Immunol 2022;13:941071. [DOI: 10.3389/fimmu.2022.941071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ho TY, Lo HY, Liu IC, Huang SL, Hsiang CY. Rosmarinic acid ameliorated psoriatic skin inflammation in mice through the novel inhibition of the interleukin-17A/interleukin-17A receptor interaction. Food Funct 2022;13:6802-12. [PMID: 35674182 DOI: 10.1039/d2fo00417h] [Reference Citation Analysis]
9 Peng S, Cheng L, Wu Q, Li Y, Ran L, Wang W, Huang K, Zhu R, Xue S, Zhou C, Zhu W, Cheng B, Fu X, Wang R. A Modified Hyaluronic Acid–Based Dissolving Microneedle Loaded With Daphnetin Improved the Treatment of Psoriasis. Front Bioeng Biotechnol 2022;10:900274. [DOI: 10.3389/fbioe.2022.900274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee WR, Chou WL, Lin ZC, Sung CT, Lin CY, Fang JY. Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis. J Control Release 2022:S0168-3659(22)00303-0. [PMID: 35623494 DOI: 10.1016/j.jconrel.2022.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ortiz-lopez LI, Choudhary V, Bollag WB. Updated Perspectives on Keratinocytes and Psoriasis: Keratinocytes are More Than Innocent Bystanders. PTT 2022;Volume 12:73-87. [DOI: 10.2147/ptt.s327310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu X, Tang X, Zhang Y, Pan Z, Wang Q, Tang L, Zhu C, Cheng H, Zhou F. Chromatin accessibility and transcriptome integrative analysis revealed AP-1-mediated genes potentially modulate histopathology features in psoriasis. Clin Epigenet 2022;14. [DOI: 10.1186/s13148-022-01250-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Choudhary V, Ajebo E, Uaratanawong R, Spaulding SC, Hossack S, Chen X, Xu J, Choudhary M, Irsik DL, Isales CM, Bollag WB. Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of Psoriasis. Int J�Tryptophan�Res 2022;15:117864692210781. [DOI: 10.1177/11786469221078191] [Reference Citation Analysis]
14 Krim D, Gomolin A, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes of births to women with psoriasis: a population-based cohort of 13 million births. J Matern Fetal Neonatal Med 2021;:1-8. [PMID: 34961404 DOI: 10.1080/14767058.2021.2020238] [Reference Citation Analysis]
15 Kutwin M, Migdalska-Sęk M, Brzeziańska-Lasota E, Zelga P, Woźniacka A. An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis. J Clin Med 2021;10:5834. [PMID: 34945130 DOI: 10.3390/jcm10245834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]